fluorobenzenes has been researched along with Heart Failure, Systolic in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aukrust, P; Block, D; Gullestad, L; Kjekshus, J; McMurray, JJ; Nymo, SH; Ueland, T; Wienhues-Thelen, UH; Wikstrand, J; Zaugg, C | 1 |
Cas, LD; Maggioni, AP; Metra, M; Nodari, S; Zacá, V | 1 |
Dunselman, P; Grande, P; Gullestad, L; Hjalmarson, A; Hradec, J; Kamenský, G; Kjekshus, J; Korewicki, J; Kuusi, T; Lindberg, M; Mach, F; McMurray, JJ; Ranjith, N; Waagstein, F; Wedel, H; Wikstrand, J | 1 |
Adourian, A; Aukrust, P; Böhm, M; Cleland, JG; Gullestad, L; Hulthe, J; Kjekshus, J; Komajda, M; McMurray, JJ; Muntendam, P; Nymo, SH; Ueland, T; van Veldhuisen, DJ; Wikstrand, J | 1 |
Wollert, KC | 1 |
Aukrust, P; Gullestad, L; Hulthe, J; Kjekshus, J; McMurray, JJ; Muntendam, P; Nymo, SH; Ueland, T; Wikstrand, J | 1 |
Jackson, G | 1 |
3 trial(s) available for fluorobenzenes and Heart Failure, Systolic
Article | Year |
---|---|
Predictive value of endostatin in chronic heart failure patients with poor kidney function.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Endostatins; Female; Fluorobenzenes; Glomerular Filtration Rate; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoenzyme Techniques; Kidney Diseases; Male; Middle Aged; Natriuretic Peptide, Brain; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2015 |
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fluorobenzenes; Galectin 3; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Lipid Metabolism; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides; Treatment Outcome | 2012 |
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Topics: Aged; Aged, 80 and over; Biomarkers; Female; Fluorobenzenes; Galectin 3; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Prognosis; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides | 2012 |
4 other study(ies) available for fluorobenzenes and Heart Failure, Systolic
Article | Year |
---|---|
[The CORONA study].
Topics: Age Factors; Aged; Aged, 80 and over; Cholesterol, LDL; Fluorobenzenes; Follow-Up Studies; Heart Failure, Systolic; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Prospective Studies; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2008 |
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Female; Fluorobenzenes; Heart Failure, Systolic; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2009 |
Tailored therapy for heart failure: the role of biomarkers.
Topics: Female; Fluorobenzenes; Galectin 3; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2012 |
CORONA--rosuvastatin in older patients with systolic heart failure.
Topics: Fluorobenzenes; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2008 |